baber/WOPTO huggingface dataset:
Patent FI-891362-A0 (FI)
Inventor: VON SPRECHER ANDREAS
IPC: C07D311/24
Filed: 1989-03-22
Abstract: Substituted alkanophenones of the general formula <IMAGE> in which R1 denotes optionally fluorinated lower alkyl, R2 represents hydrogen, optionally fluorinated lower alkyl or lower alkenyl, X denotes lower alkylene, oxy, thio or a direct bond, alk represents lower alkylene, n stands for 1 or 2, R3 denotes phenyl which is unsubstituted or substituted by optionally fluorinated lower alkyl, etherified or esterified hydroxyl, optionally lower alkylated amino and/or optionally esterified or amidated carboxyl or denotes lower alkyl which is optionally fluorinated or substituted by optionally esterified or amidated carboxyl, R4 represents optionally esterified or amidated carboxyl or 5-tetrazolyl and R5 stands for hydrogen or lower alkyl, have leukotriene-antagonist properties and can be used as antiallergic pharmaceutical active compounds. The process for their preparation is characterised in that an epoxide of the formula <IMAGE> in which R1, R2, X, alk, n and R3 have the above meanings, is reacted with a thiol of the formula <IMAGE> in which R4 and R5 have the above meanings, or a salt thereof and, if desired, a compound obtainable according to the process is converted into another compound of the formula I, a stereoisomer mixture obtainable according to the process is resolved into the components and/or a free compound obtainable according to the process is converted into a salt or a salt obtainable according to the process is converted into the free compound or into another salt.
Patent FI-891422-A0 (FI)
Inventor: JANSSEN PIETER
IPC: E04B2/96
Filed: 1989-03-23
Abstract: The transom (1) and the mullion (29), which are connected via a T-connection, possess an inner chamber (2) and (32) respectively, a connector (3) being arranged in the inner chamber of the transom, to be precise at the front end. This connector possesses a front plate which faces the joint and in which a collar bolt is mounted so that it can slide and so that it is rotationally fixed by means of a stop plate (22) guided between cheeks (23). The collar bolt is loaded with a spring (24). 
<??>The object of the invention is to achieve a positive connection between the connector profile and the mullion without additional fastening means introduced into the mullion from outside and to dispense with screws screwed into the transom from outside in order to fix the connector in the inner chamber of the transom. 
<??>To achieve this object, the collar bolt (21) possesses at least one catch recess (26) in the region of its length projecting outwards beyond the front plate. Provided between the platelike legs of the connector body, which is of U-shaped configuration in longitudinal section, is a bridge piece (7) which is designed in the manner of a toggle lever and is equipped with a threaded bore for a clamping screw (11) resting with its head against the front wall. On tightening the clamping screw, the legs, previously coated on the outside with adhesive, spread in the direction of the inner face of the transom so that a perfect adhesive bond is achieved. 
<??>The object of the application is used in the construction of attached facades with a supporting structure made of profiled rails, i.e. in building construction. 
<IMAGE>
Patent FI-913320-A0 (FI)
Inventor: PYRET THOMAS
IPC: A61M5/32
Filed: 1991-07-09
Abstract: An applicator for administering a veterinary pharmacological composition comprises a container having a cannula extending therefrom and a two-piece cap for releasably covering the cannula. The cap has an internal seal for sealing the cannula against leakage and contamination.
Patent FI-920164-A0 (FI)
Inventor: BARCLAY BRIAN L
IPC: A61K9/22
Filed: 1992-01-14
Abstract: An osmotic device for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a wall surrounding a compartment housing a layer of an agent that is insoluble to very soluble in aqueous biological fluid, e.g., saliva, and a layer of a fluid swellable, hydrophilic polymer. A passageway in the wall connects the agent with the exterior of the device. The wall is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer. In one embodiment the beneficial agent has a different color than the hydrophilic polymer. The wall is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent remaining to be delivered. Marking lines may be provided on the wall indicating the amount of drug/agent which has been delivered and/or the amount remaining to be delivered.
Patent FI-923374-A0 (FI)
Inventor: BRAGE NILS ANDERS
IPC: F41A1/10
Filed: 1992-07-24
Abstract: PCT No. PCT/SE91/00065 Sec. 371 Date Jul. 29, 1992 Sec. 102(e) Date Jul. 29, 1992 PCT Filed Jan. 29, 1991 PCT Pub. No. WO91/11673 PCT Pub. Date Aug. 8, 1991.A countermass for a recoilless weapon which is intended to be placed behind the propellant charge of the weapon projectile and intended to depart together with the propellant gases that exit from the rearward end of the weapon when the projectile is projected forward. The countermass includes a plurality of mutually sequential and separated countermass bodies, each of which has a gas throughflow passage. The throughflow passage in the countermass bodies is sized to have a larger inlet area in bodies at the forward end of the countermass and gradually smaller inlet area in bodies at the rearward end of the countermass.
Patent FI-925772-A0 (FI)
Inventor: BERGLUND SVANTE
IPC: F16K/
Filed: 1992-12-18
Abstract: A valve arrangement comprises a valve housing (4) which has a valve chamber (7, 13, 15) with an outlet (9, 10, 11, 12) and an inlet (16) which is adapted to be connected to a pressure-medium source (25), and a valve opening communicating with the valve chamber. A control valve (8, 22) is mounted on the valve housing (4) to close the outlet of the valve chamber when in closed position, and open this outlet when in open position. A main valve (14, 17) mounted on the valve housing (4) has, in the valve opening, a valve member (17) which is movable in response to the pressure in the valve chamber (7, 13, 15) between an outer closing position and an inner opening position. The inlet (16) of the valve chamber extends through the wall of the valve housing (4).
Patent FI-931281-A0 (FI)
Inventor: OKPANYI SAMUEL N
IPC: A61K36/31
Filed: 1993-03-23
Abstract: Plant-based medicament having tonicising action on smooth muscular organs which are atonic or have decreased tone. The medicament contains Iberis amara, preferably Iberis amara totalis (flowers, seeds, leaves, stalk and roots), in particular as a plant extract or its constituents, optionally together with one or more other constituents selected from the group consisting of Menthae piperitae, Matricariae, Carvi fructus, Melissae folium and Liquiritiae radix, as the sole carrier(s) of the activity. Methods of treating patients comprising administering the medicaments.
Patent FI-933219-A0 (FI)
Inventor: ADAMSON LINDA ANN
IPC: C08L75/00
Filed: 1993-07-15
Abstract: A method for extending the open time of an aqueous coating composition is provided. This method extends the time during which an aqueous coating can be applied or rebrushed without damaging the film The open time improvement of this invention is useful for a variety of coatings including paints, stains, varnishes, adhesives, and inks. The aqueous coating composition contains a latex polymer and a modifying compound. More particularly, the latex polymer contains a first reactable group which is complementary to and reacts with a second reactable group in the modifying compound. The complementary reactable groups in the latex polymer and modifying compound provide ionic or covalent binding.
Patent FI-950552-A0 (FI)
Inventor: NEILL PAUL
IPC: A61K8/46
Filed: 1995-02-08
Abstract: A mild permanent wave reducing agent-containing composition includes two ionic compounds, one cationic and the other anionic, that complex in solution over a molar ratio of cationic compound to anionic compound in the range of 1:1.2 to 1.2:1. The cationic compound, in solution, forms a cation of formula I or formula II, or a mixture of two or more thereof; <CHEM>   <CHEM> wherein R1, R2, R3, R5, R6 and R7, same or different, are H, an alkyl group or hydroxyalkyl group having 1 to 5 carbon atoms; and R4 is OH, -OR8 or -NR9R10, wherein R8, R9 and R10, same or different, are H, an alkyl group or hydroxyalkyl group having 1 to 4 carbon atoms, A is an alkylene group having 1 to 5 carbon atoms; and B is O or S; and the anionic compound. in solution, forms an anion of formula III: <CHEM> wherein A is nonexistent or an alkylene group having 1 to 5 carbon atoms, and Y is H, OH, NH2 or <CHEM> wherein R12 is an alkyl group having 1 to 5 carbon atoms. Examples of cationic compounds include thiocholine, choline, cysteineamide, cysteamine, and combinations thereof. Examples of anionic compounds include cysteine, N-acetylcysteine, thioglycolic acid or its salts, and combinations thereof.
Patent FI-950877-A0 (FI)
Inventor: HYVOENEN HANNU
IPC: F16N7/38
Filed: 1995-02-27
Abstract: The invention concerns a system for control and monitoring of the circulation lubrication of the bearings of the revolving cylinders and rolls (20... 27) in a paper machine or equivalent, in which system, lubrication oil is fed from an oil-lubrication center or centers (30A,30B) through a system of pipes (32,34,36) into the lubrication points (20... 27). From these the lubricant is passed back through a system of return pipes (37,35,33) into the oil-lubrication center or centers (30A,30B). The system comprises a number of actuator panels (50), which are placed and grouped in the vicinity of the lubrication points primarily above the floor level (L-L) of the paper machine hall or equivalent. From the actuator panels (50) lubricant feed pipes (38) are passed to a number of lubrication points (20...27) placed in the vicinity. The actuator panels (50) comprise a feed-back connected regulation loop (52...57) for lubricant flow quantity, provided for each lubrication point (20...27), which regulation loop comprises an oil-flow regulation valve (56), an actuator motor (55) for same, as well as an oil-flow measurement device (57) and a regulation circuit (52). <IMAGE>
Patent FI-953462-A0 (FI)
Inventor: HEDMAN LARS
IPC: E02B8/02
Filed: 1995-07-18
Abstract: PCT No. PCT/SE94/00062 Sec. 371 Date Sep. 22, 1995 Sec. 102(e) Date Sep. 22, 1995 PCT Filed Jan. 28, 1994 PCT Pub. No. WO94/24373 PCT Pub. Date Oct. 27, 1994A strainer for removing particles from a horizontal flow of effluent comprises a plurality of parallel fixed bars adapted to extend angularly downwardly into the flow of effluent and a set of parallel displaceable bars interdigited with the fixed bars. The displaceable bars are interconnected and connected to a drive mechanism to cause the displaceable bars to move in a circuitous path such that the displaceable bars move upwardly relative to the fixed bars to remove material engaged thereon and are thence thereafter lowered, whereby the material is lifted upwardly along the fixed bars. The displaceable bars are supported at their lower ends to the drive mechanism by a flexible connection apparatus so that the path of movement of the displaceable bars is unconstrained to minimize stress on the strainer should debris become lodged beneath the lower end of the displaceable bars.
Patent FI-962043-A0 (FI)
Inventor: ZOLLER GERHARD
IPC: C07D401/12
Filed: 1996-05-14
Abstract: 5-Membered ring heterocycle of the formula I,in which D includes a COOR15, CON(CH3)R15 or CONHR15 radical and R15 includes a 6-24 member bicyclic or tricyclic radical, compositions, preparation and use as inhibitors of thrombocyte aggregation, metastasization of carcinoma cells, binding of osteoclasts to bone surfaces and for the treatment of tromboses.
Patent FI-971663-A0 (FI)
Inventor: KARVO MIKKO KALEVI
IPC: C09F1/02
Filed: 1997-04-18
Abstract: The invention relates to a process for the preparation of a tall oil rosin ester with a low odor level, which process comprises an esterification step wherein a tall oil rosin is esterified with a polyol in order to form a product which contains a tall oil rosin ester, and evaporation is carried out on this product in order to remove odor components and other volatile components from the product, which evaporation is carried out in a short-path evaporator which has an evaporation surface and, in the vicinity of this surface, a condenser on which the vaporized components to be removed condense, whereupon a tall oil rosin ester with a low odor level is recovered from the evaporator.
Patent AP-9701018-A0 (AP)
Title: Squalene synthetase inhibitor compounds.
Inventor: HAMANAKA ERNEST S
IPC: C07D417/06
Filed: 1997-06-19
Abstract: This invention relates to certain benzoxazepinones and benzothiazepinones useful as hypocholesterolemic agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, anti-alzheimer's agents ot anti-acne agents
Patent AP-9701142-A0 (AP)
Title: 4,4-(Disubstituted) cyclohexan-1-ols monomers and related compounds.
Inventor: CHRISTENSEN SIEGFRIED BENJAMIN
IPC: C07C255/40
Filed: 1996-05-30
Abstract: The present invention related to novel 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compsitions containing these compounds, and their use in treating allergic and inflammatiry diseases and for inhibiting the production of tumor necrosis factor (tnf).
Patent IL-71299-A0 (IL)
Title: Radiation scatter apparatus and method
IPC: G01B15/02
Filed: 1984-03-21
Abstract: A radiation scatter gauge (10) comprises a radiation source (20) and multiple detectors (22,24,26) for developing separate and independent sets of data from which multiple physical characteristics of a thin material (T) and underlying substrate (B) may be determined. The apparatus and method of the invention are directed to determining characteristics of resurfaced pavement by nondestructive testing. More particularly,the density and thickness of a thin asphalt overlay (t) and the density of the underlying pavement (B) may be determined.
Patent IL-73206-A0 (IL)
Title: Polymer-catalyst transducer and its use
IPC: G01N27/12
Filed: 1984-10-09
Abstract: Polymer-catalyst tranducers and their use for detecting one or more constituents in a sample are disclosed. Changes in conductivity of the polymercatalyst transducers as a result of electron density changes are measured to provide an indication of a particular constituent present in the sample. Such conductivity changes can be measured using a conductivity meter. The polymer-catalyst tranducers are particularly useful for the determination of glucose in whole blood.
Patent IL-89056-A0 (IL)
Title: Method of enhancing mental function
IPC: A61K38/31
Filed: 1989-01-24
Abstract: The mental functions of an individual are enhanced by the administration of a hypothalamic hypophsyiotropic hormone to that individual.
Patent AU-PN160495-A0 (AU)
Title: Animal lifting means
IPC: A01K15/00
Filed: 1995-03-09
Abstract: PCT No. PCT/AU96/00134 Sec. 371 Date Sep. 5, 1997 Sec. 102(e) Date Sep. 5, 1997 PCT Filed Mar. 12, 1996 PCT Pub. No. WO96/28017 PCT Pub. Date Sep. 19, 1996An animal lifting apparatus comprising a frame including longitudinal members, forward strut, rear strut on which is mounted a hindquarter support, a harness support attached to frame gambrel being connected to a frame by straps, received by slots in outriggers extending from the spine of gambrel, and the gambrel being connectable to a weight lifting device via a chain passing through an eye.
Patent AU-PP627398-A0 (AU)
Title: Novel peptides - II
IPC: A61P9/06
Filed: 1998-10-02
Abstract: The present invention relates to novel peptides and derivatives thereof useful as selective alpha1-adrenoceptor antagonists which ability of inhibiting the agonist action of agonist noradrenaline on the alpha1-adrenoceptor is greater than their ability of inhibiting the action of agonist noradrenaline on the other alpha-adrenoceptors. The invention also relates to pharmaceutical compositions comprising these peptides.
Patent FI-20115098-A0 (FI)
Inventor: HARTIKKA YRJOE
IPC: H05B44/00
Filed: 2011-01-31
Abstract: A LED tubular lamp comprising a translucent tube (30) of the shape and size of a fluorescence tube with a contact pin pair (37, 38, 39, 40) at both ends thereof for connecting a LED tube mechanically and electrically to the tube holders of the fluorescent tube lighting fixture. LED components (32) and a current control unit (33, 34) are installed inside the LED tube. The LED tubular lamp also comprises a voltage level sensor circuit (42, 43) that is arranged to detect automatically a voltage difference in the contact pin pair at least at one end of the tube and to determine from the voltage difference brightness and/or colour control information for the current control unit (33, 34) of the LED components.
Patent IL-111479-A0 (IL)
Title: Chimeric proteins comprising borrelia polypetides and uses therefor
IPC: C12N15/31
Filed: 1994-10-31
Abstract: Novel chimeric nucleic acids, encoding chimeric Borrelia proteins consisting of at least two antigenic polypeptides from corresponding and/or non-corresponding proteins from the same and/or different species of Borrelia, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
Patent IL-114479-A0 (IL)
Title: Process for reducing lead leachate in brass plumbing components
IPC: E03B7/09
Filed: 1995-07-06
Abstract: Treatment of brass components to reduce leachable Pb when subsequently exposed to water, comprises: (a) exposing the components to an aq. soln. contg. 0.17-2.1M chloride and 0.06-0.27M pyrophosphate; (b) maintaining the exposure for 3.5-30 minutes at 35-70 deg.C. Also claimed is the above process wherein the components are exposed to an aq. soln. contg. 2 kinds of active species, one which promotes the dissolution of Pb from the brass, esp. chloride ions; and a species which sequesters the dissolved Pb in soln., preventing Pb reaction from reaching equilibrium, esp. pyrophosphate.
Patent IL-117811-A0 (IL)
Title: N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them
IPC: A61P3/10
Filed: 1996-04-03
Abstract: The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.
Patent IL-139858-A0 (IL)
Title: Signal noise reduction by spectral subtraction using spectrum dependent exponential gain function averaging
IPC: G10L15/20
Filed: 1999-05-27
Abstract: Methods and apparatus for providing speech enhancement in noise reduction systems include spectral subtraction algorithms using linear convolution, causal filtering and/or spectrum dependent exponential averaging of the spectral subtraction gain function. According to exemplary embodiments, successive blocks of a spectral subtraction gain function are averaged based on a discrepancy between an estimate of a spectral density of a noisy speech signal and an averaged estimate of a spectral density of a noise component of the noisy speech signal. The successive gain function blocks are averaged, for example, using controlled exponential averaging. Control is provided, for example, by making a memory of the exponential averaging inversely proportional to the discrepancy. Alternatively, the averaging memory can be made to increase in direct proportion with decreases in the discrepancy, while exponentially decaying with increases in the discrepancy to prevent audible voice shadows.
Patent IL-145911-A0 (IL)
Title: Gastric stimulator apparatus and method for use
IPC: A61N1/05
Filed: 2000-04-14
Abstract: Apparatus and method for stimulating neuromuscular tissue in the stomach. The neuromuscular stimulator stimulates the neuromuscular tissue by applying current-controlled electrical pulses. A voltage sensor detects the voltage across the neuromuscular tissue to determine if the voltage meets a predetermined voltage threshold. A control circuit adjusts the current-controlled pulse if the voltage is found to meet the voltage threshold, such that the voltage does not exceed the voltage threshold. A voltage-controlled pulse may also be applied to the tissue. A current sensor would then detect whether the current on the neuromuscular tissue meets a predetermined current threshold, and a control circuit adjusts the voltage-controlled pulse such that the current does not exceed the current threshold. A real time clock may be provided which supplies data corresponding to the time of day during the treatment period. A programmable calendar stores parameters of the stimulating pulse, wherein the parameters have a reference to the time of day.
Patent IL-154975-A0 (IL)
Title: Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
IPC: A61P35/00
Filed: 2001-10-17
Abstract: The present invention relates to methods and uses for preventing or treating hormone-dependent disease, in particular breast cancer, in a mammal by antiprogestins, in particular antiprogestin 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a pharmaceutically acceptable derivative or analogue thereof. The invention further relates to pharmaceutical compositions comprising said antiprogestin.
Patent IL-155060-A0 (IL)
Title: Method for electrochemically producing hydrogen peroxide
IPC: C25B1/30
Filed: 2001-09-06
Abstract: A process for the electrochemical preparation of hydrogen peroxide, in particular an aqueous hydrogen peroxide solution, by the electrochemical reaction of oxygen and hydrogen in a fuel cell. By increasing the thickness of the membrane layer in a membrane electrode unit (MEU) in the fuel cell, it is possible to substantially increase the concentration of H2O2 in the aqueous hydrogen peroxide solution obtained at the cathode.
Patent IL-172022-A0 (IL)
Title: A method for applying a polymer coating to the internal surface of a container
IPC: B65D81/24
Filed: 2005-11-17
Abstract: Provided is a method for the application of a polymer coating to an internal surface of a container, which method comprises: (a) heating the inside surface of the container to be coated; (b) spraying an aqueous suspension of a fluorine-containing polymer onto the surface to form a coating on the surface; and (c) sintering the coating; wherein the container comprises a base and one or more side walls defining a container opening and is suitable for storing a medicament, and wherein the spraying step is conducted with a first spraying means configured to produce an axial spray pattern that is substantially conical about an axis perpendicular to the container base.
Patent IL-172898-A0 (IL)
Title: Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
IPC: A61P3/06
Filed: 2005-12-29
Abstract: The present invention relates to the use of a composition for treating, preventing and/or improving metabolic dysfunctions associated with Type 2 diabetes mellitus and insulin resistance, said composition comprising intact whey protein, and to nutritional or pharmaceutical compositions and functional food products.